Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-03 Jackson Blair Curtis EVP, Chief Operating Officer Exercise or conversion +34,503 $18.11 $625K 102,657
2021-05-03 Jackson Blair Curtis EVP, Chief Operating Officer Sale −34,503 $22.18 $765K 68,154
2021-05-03 Jackson Blair Curtis EVP, Chief Operating Officer Exercise or conversion · Employee Stock Option (Right to Buy) −34,503 0
2021-04-19 DIXON WENDY L Director Exercise or conversion +25,000 $14.60 $365K 61,600
2021-04-19 DIXON WENDY L Director Sale −25,000 $20.00 $500K 36,600
2021-04-19 DIXON WENDY L Director Exercise or conversion · Non Qualified Stock Option (Right to Buy) −25,000 0
2021-04-19 Brown Iain Michael SVP, Chief Financial Officer Exercise or conversion +34,792 $18.11 $630K 83,154
2021-04-19 Brown Iain Michael SVP, Chief Financial Officer Sale −34,792 $20.00 $696K 48,362
2021-04-19 Brown Iain Michael SVP, Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −34,792 0
2021-04-16 Brown Iain Michael SVP, Chief Financial Officer Exercise or conversion +208 $18.11 $4K 48,570
2021-04-16 Brown Iain Michael SVP, Chief Financial Officer Sale −208 $19.99 $4K 48,362
2021-04-16 Brown Iain Michael SVP, Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −208 34,792
2021-04-15 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale −28,920 $19.72 $570K 0
2021-02-22 POPS RICHARD F Director and CEO, Alkermes plc Grant or award · Employee Stock Option (Right to Buy) +342,187 342,187
2021-02-22 Nichols Christian Todd SVP, Chief Commercial Officer Grant or award · Employee Stock Option (Right to Buy) +113,754 113,754
2021-02-22 Nichols Christian Todd SVP, Chief Commercial Officer Grant or award · Restricted Stock Unit Award +27,877 27,877
2021-02-22 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Grant or award · Employee Stock Option (Right to Buy) +90,487 90,487
2021-02-22 LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. Grant or award · Restricted Stock Unit Award +22,175 22,175
2021-02-22 Jackson Blair Curtis EVP, Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +155,119 155,119
2021-02-22 Jackson Blair Curtis EVP, Chief Operating Officer Grant or award · Restricted Stock Unit Award +38,014 38,014

Page 65 of 75 · 1,492 trades